Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sahanic (Innsbruck, Austria), T. Sonnweber (Innsbruck, Austria), A. Pizzini (Innsbruck, Austria), G. Widmann (Innsbruck, Austria), A. Luger (Innsbruck, Austria), M. Aichner (Innsbruck, Austria), A. Böhm (Innsbruck, Austria), G. Weiss (Innsbruck, Austria), C. Tschurtschenthaler (Innsbruck, Austria), V. Petzer (Innsbruck, Austria), D. Haschka (Innsbruck, Austria), M. Theurl (Innsbruck, Austria), D. Lener (Innsbruck, Austria), S. Wildner (Innsbruck, Austria), R. Bellmann-Weiler (Innsbruck, Austria), E. Wöll (Zams, Austria), J. Löffler-Ragg (Innsbruck, Austria), I. Tancevski (Innsbruck, Austria). Late Breaking Abstract - Persisting pulmonary impairment following severe SARS-CoV-2 infection, preliminary results from the CovILD study. 4143

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Effects of pulmonary rehabilitation on major symptoms of long COVID (post-COVID-19 syndrome): preliminary results Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 Late Breaking Abstract - Lung involvement is clue for recognizing severe dengue-A retrospective study Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Late Breaking Abstract - 12-month lung clinical and functional consequences in patients with severe COVID-19 Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Late Breaking Abstract - Physical activity recovery in patients with COVID-19 infection included in pulmonary rehabilitation Source: Virtual Congress 2021 – COVID-19: insights from respiratory physiotherapists Year: 2021 Late Breaking Abstract - IPF symptoms’ course during a 3-month observation: FIBRONET observational study’s preliminary results. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 Late Breaking Abstract - Reported outcomes in patients referred with persisting respiratory symptoms following non-hospitalised COVID-19 Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021 Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Molecular mechanisms involved in early stage of pulmonary hypertension: experimental study Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017 Late Breaking Abstract - Increased risk of pulmonary embolism in patients with radiological severe COVID-19 pneumonia Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Late Breaking Abstract - Acute multi-organ symptoms predict long COVID Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Late Breaking Abstract - Organoids and lung-on-chip to study SARS-CoV-2-mediated lung injury Source: Virtual Congress 2020 – Covering COVID - the best abstracts Year: 2020 Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Late Breaking Abstract - Automated coaching for physical activity in COPD patients: results from a pilot study Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care Year: 2017 Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - A novel bronchoscopic lung volume reduction device for severe emphysema: a preclinical study in pigs Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations Year: 2018 Late Breaking Abstract: Is asthma really affecting your work? Respiratory work disability in a longitudinal population-based study Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease Year: 2010 Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019